Identification of Enerzair Breezhaler:
No description |
Search images on Google Product Monograph
Active Ingredients:
- indacaterol (indacaterol acetate), 150 MCG
- glycopyrronium (glycopyrronium bromide), 50 MCG
- mometasone furoate, 160 MCG
DIN: 02501244
Dosage Form(s): CAPSULE
Route(s) of Administration: INHALATION
Schedule: Prescription
Company: NOVARTIS PHARMACEUTICALS CANADA INC – official site
ATC:
- R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, WHO, Wiki)
- R03A - ADRENERGICS, INHALANTS (ATC, WHO)
- R03AL - Adrenergics in combination with anticholinergics (ATC, WHO)
- R03AL12 - INDACATEROL, GLYCOPYRRONIUM BROMIDE AND MOMETASONE (WHO)
External Links for Enerzair Breezhaler:
Search on Google
- Enerzair Breezhaler side effects
- Enerzair Breezhaler dosage
- indacaterol side effects
- indacaterol dosage
- glycopyrronium side effects
- glycopyrronium dosage
- mometasone furoate side effects
- mometasone furoate dosage
Novartis Pharmaceuticals Canada Inc
Go to Novartis website to see drug product details. Sometimes you can find enerzair breezhaler photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.